Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Brain Res. 2020 Feb 6;1735:146717. doi: 10.1016/j.brainres.2020.146717

Defining the adult hippocampal neural stem cell secretome: in vivo versus in vitro transcriptomic differences and their correlation to secreted protein levels

JK Denninger 1, X Chen 2, AM Turkoglu 3, P Sarchet 2, AR Volk 3, JD Rieskamp 4, P Yan 2,5, ED Kirby 1,6,7
PMCID: PMC7199439  NIHMSID: NIHMS1576778  PMID: 32035887

Abstract

Adult hippocampal neural stem and progenitor cells (NSPCs) secrete a variety of proteins that affect tissue function. Though several individual NSPC-derived proteins have been shown to impact key cellular processes, a broad characterization is lacking. Secretome profiling of low abundance stem cell populations is typically achieved via proteomic characterization of in vitro, isolated cells. Here, we identified hundreds of secreted proteins in conditioned media from in vitro adult mouse hippocampal NSPCs using an antibody array and mass spectrometry. Comparison of protein abundance between antibody array and mass spectrometry plus quantification of several key secreted proteins by ELISA revealed notable disconnect between methods in what proteins were identified as being high versus low abundance, suggesting that data from antibody arrays in particular should be approached with caution. We next assessed the NSPC secretome on a transcriptional level with single cell and bulk RNA sequencing (RNAseq) of cultured NSPCs. Comparison of RNAseq transcript levels of highly secreted proteins revealed that quantification of gene expression did not necessarily predict relative protein abundance. Interestingly, comparing our in vitro NSPC gene expression data with similar data from freshly isolated, in vivo hippocampal NSPCs revealed strong correlations in global gene expression between in vitro and in vivo NSPCs. Understanding the components and functions of the NSPC secretome is essential to understanding how these cells may modulate the hippocampal neurogenic niche. Cumulatively, our data emphasize the importance of using proteomics in conjunction with transcriptomics and highlights the need for better methods of unbiased secretome profiling.

1. Introduction

In the adult mammalian brain, neural stem cells (NSCs) are located in two specific niches, the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) (Gage and Temple 2013). In the adult SGZ, resident radial glia-like NSCs (RGL-NSCs) produce intermediate progenitor cells (IPCs) that proliferate throughout the lifespan of the organism to produce functionally-relevant neurons and astrocytes (Ming and Song 2011). In addition to creating mature cell types, NSCs also secrete an array of growth factors and cytokines, collectively termed the stem cell secretome (Drago et al. 2013; Bacigaluppi et al. 2020). In the healthy adult SGZ, RGL-NSCs and their progenitors (together NSPCs) have been shown to produce the secreted factors milk-fat globule EGF-factor 8 (MFGE8) and vascular endothelial growth factor (VEGF), both of which regulate NSPC maintenance through autocrine signaling (Kirby et al. 2015; Zhou et al. 2018), as well as PTN which drives maturation of immature, developing neurons (Tang et al. 2019). However, while the secretome of other tissue stem cells, such as mesenchymal stem cells, has been extensively catalogued (Liang et al. 2014; Teixeira and Salgado 2020), a comprehensive characterization of the NSPC secretome is lacking (Andres et al. 2011; Ryu et al. 2004; Yasuhara et al. 2006; Ourednik et al. 2002; Tang et al. 2019; Bacigaluppi et al. 2020).

Protein-level analysis of the stem cell secretome is typically accomplished using in vitro models, where the conditioned media (CM) of isolated stem cells is profiled using proteomics approaches such as antibody-based arrays or liquid chromatography-mass spectrometry (LC-MS). While these approaches have provided the first broad understanding of the content and variety of several tissue stem cell secretomes (Skalnikova et al. 2011), they are limited by two main factors: 1) in the case of arrays, the scope and specificity of the pre-selected antibodies present on the arrays and 2) in both cases, potential differences in protein production in in vitro versus in vivo systems.

Commercial antibody arrays are thus far the most common method for secretome identification because the arrays can contain antibodies for hundreds to thousands of proteins and can be used with CM from standard culture conditions, including those with high levels of serum-derived protein supplements. However, the list of potentially detected targets is still confined to the pre-identified targets and specificity of those hundreds to thousands of antibodies can be impractical to verify. LC-MS, in contrast, can yield a more unbiased identification of proteins in CM with less likelihood of false signals than antibody arrays, but traditionally requires serum deprivation of cells to detect cell-secreted proteins. Serum deprivation can dramatically disrupt numerous cell processes and change the secretome (Pirkmajer and Chibalin 2011).

While the issue of culture-induced change in protein secretion is particularly severe when serum deprivation is required as with LC-MS, it can also be problematic when studying the secretome in standard culture conditions. Comparison of cultured cells to their in vivo counterparts in several organ systems has provided increasing evidence of significant changes that occur when cells are transitioned from an in vivo to an in vitro environment (Durr et al. 2004; Binato et al. 2013; Duggal et al. 2009). These changes are dependent both on the method of isolation (Wernly et al. 2017) and the conditions of culture maintenance (Shahdadfar et al. 2005; Duggal and Brinchmann 2011). More specific to NSPCs, key differences in gene expression of inflammatory and cytokine signaling factors were identified in vitro SVZ NSCs versus in vivo NSCs freshly isolated from the SVZ (Dulken et al. 2017).

The potential hazards of in vitro analysis of stem cell secretomes suggest that in vivo approaches might be superior. However, high-throughput characterization of tissue stem cell secretomes in vivo faces several challenges, as well. In vivo, adult tissue stem cells, including hippocampal NSPCs, are small populations residing in heterogeneous niches that impede sufficient isolation of cells that are necessary for most large-scale proteomics protocols. Methods such as immunostaining of tissue sections or flow cytometry of dissociated cells allow detection of pre-selected proteins in specific cells, but are limited in the total number and type of proteins that can be examined in each instance. To broaden the scope of in vivo protein investigation, extracellular factors can be identified from tissue niches with high performance liquid chromatography (HPLC) or mass spectrometry of microdialysates. However, these methods fail to determine the cells that produce the secreted factors. In contrast to proteomic approaches, high throughput RNA sequencing (RNAseq) is adaptable to low cell input and several studies have recently provided large-scale quantification of gene expression in acutely isolated NSPCs by single cell RNAseq (scRNAseq) (Hochgerner et al. 2018; Shin et al. 2015; Artegiani et al. 2017; Dulken et al. 2017; Zywitza et al. 2018). However, transcriptional activity does not always correlate well with bioavailable protein due to added layers of regulation on translational and post-translational levels (Lipshitz, Claycomb, and Smibert 2017; Besse and Ephrussi 2008).

Given that mRNA levels may not reflect secreted protein levels and in vitro gene expression may not mirror in vivo expression, we chose to create a multi-faceted analysis of the adult hippocampal DG NSPC secretome from mRNA level to secreted protein of in vitro cultured NSPCs. For high-throughput protein-level quantification, we used a protein array to probe for over 300 different cytokines and growth factors secreted by cultured adult hippocampal NSPCs. Furthermore, we performed unbiased LC-MS based analyses of in vitro NSPC intracellular and secreted proteins. Secreted proteins were identified without any supplement deprivation by using biorthogonal non-canonical amino acid tagging (BONCAT) of newly synthesized proteins to select and enrich for proteins synthesized by NSPCs in the CM (Dieterich et al. 2006). We next compared these protein-level data with transcriptional-level data derived from bulk and single cell RNAseq of similarly maintained in vitro NSPCs to reveal the potential relationship between transcriptional expression and protein expression and secretion. Last, to evaluate the equivalence of in vitro and in vivo NSPCs, we examined two independently published single cell sequencing datasets of endogenous, in vivo hippocampal NSPCs (Shin et al. 2015; Hochgerner et al. 2018). Comparison of all these datasets demonstrated important divergence between transcriptional and translational expression, and also an overall agreement between cultured and in vivo hippocampal NSPC transcriptional expression. Our findings therefore not only provide a broad characterization of the putative adult DG NSPC secretome, but also highlight the need to consider limitations of currently available methods for secretome profiling.

2. Results

2.1. Protein array of cultured adult hippocampal NSPC conditioned media detects several secreted factors that impact NSPC function.

Adult hippocampal NSPC cultures were established from male and female C57Bl6 mice (n=4 mice per line) and maintained according to previously published methods (Babu et al. 2011; Kirby et al. 2015). As expected, when maintained in proliferative conditions, these cultures showed immunoreactivity for NSPC markers NESTIN, GFAP, and Ki67 (Fig. 1A) and when under differentiating culture conditions, they generated β3-Tubulin+ neurons and S100β+ astrocytes (Supplemental Fig. 1AD). To further examine the NSPC phenotype of these cells, four separate cultures of adult hippocampal NSPCs (two male and two female) were harvested and analyzed by bulk RNA sequencing. Over 25,000 unique transcripts were detected (Supplemental Table 1). Examination of known transcriptional markers for quiescent RGL-NSCs (qRGLs), activated RGL-NSCs (aRGLs), and IPCs indicated that cultured NSPCs mainly consisted of quiescent and activated RGL-NSCs (Fig. 1B) (Shin et al. 2015; Hochgerner et al. 2018). These subpopulations were confirmed with single cell (sc)RNAseq on 14,912 cultured NSPCs from three independent passages of cells. Unsupervised clustering analysis of the transcriptional data was visualized on a t-distributed stochastic neighbor embedding (t-SNE) plot which yielded 6 clusters that were all enriched for markers of RGL-NSCs such as Nestin and Fabp7 (Fig. 1C and Supplemental Fig. 1E). Several clusters of cells showed high expression of gene markers for aRGLs such as Cdk1 and Top2a, and one cluster (cluster 0) showed enrichment for markers associated with qRGLs, such as Apoe and Aldoc (Supplemental Fig. 1E). These data indicated that NSPC cultures consisted mainly of quiescent and activated NSCs (Fig. 1B and C). GO term analysis of differentially expressed genes (DEGs) between the clusters revealed that the clusters appeared to separate most strongly based on stages in cell cycle (Fig. 1D, Supplemental Table 2). Specifically, biological process GO term enrichment revealed a progression counterclockwise from group 3 to 2 to 4 to 1 with DEGs associated with DNA synthesis to mitotic spindle assembly to chromosome segregation and separation, and finally to mitosis and cytokinesis. These data suggested that groups 3, 2, 4, and 1 represented activated NSCs as they progressed through cell cycle phases: G1, S, G2, mitosis, and cytokinesis (Supplemental Fig. 1F). Group 5 DEGs were enriched for GO terms associated with several aspects of translation and possibly represents early IPCs, as translation processes have been shown to be upregulated at this phase of differentiation (Shin et al. 2015).

Fig. 1.

Fig. 1.

Characterization of in vitro cultured NSPCs. (A) Immunofluorescent staining of known NSPC markers NESTIN, GFAP, and KI67. (scale bar = 50 μm) (B) Heatmap of log fold change of gene length normalized transcript expression in NSPCs over whole DG expression from bulk RNAseq of cultured NSPCs and whole DG. (C) tSNE plot of clustering analysis for scRNAseq of cultured NSPCs. (D) Heatmap of fold enrichment values for top 20 GO biological process terms from differentially expressed genes defining each scRNAseq cluster.

To provide an initial assessment of the secretome derived from these cultured NSPCs, conditioned media (CM) from three separate adult hippocampal NSPC cultures (one male and two female) were collected and probed for over 300 growth factors, cytokines, chemokines, adipokines, angiogenic factors, proteases, soluble receptors and soluble adhesion molecules with a protein antibody array. Supplemental Table 3 lists the fluorescence values after normalization to average fluorescence intensity within each slide for all factors that were detected in the assay ranked by Z-score. Of these, the top 50 most highly detected factors were selected for further scrutiny (Fig. 2A). One of the top intensity factors was vascular endothelial growth factor (VEGF), which we previously identified as highly secreted by NSPCs and critical for stem cell maintenance in vivo and in vitro (Kirby et al. 2015). In addition, many other soluble growth factors and cytokines showed high signal intensity, along with several carrier proteins that are implicated in NSPC maintenance such as those of the IGFBP family (IGFBP3, IGFBP2, and IGFBP5) (Kalluri and Dempsey 2011; Shen et al. 2019; Barkho et al. 2006). Soluble fragments of receptors that promote NSPC maintenance and proliferation, such as TYRO3, were also found, possibly reflecting shedding of the extracellular portions from these typically membrane-integral receptors (Ji et al. 2014). Known regulators of apoptosis that promote NSPC survival, FAS and SPP1, were also detected in the top 50 signals (Knight, Scharf, and Mao-Draayer 2010; Rabenstein et al. 2015). CD70 on NSPCs, shown to interact with CD27 on CD4+ T-cells to induce FAS-mediated apoptosis of T cells, was also detected (Lee et al. 2013). Cumulatively, the protein array indicated the presence of several previously reported components of the NSPC secretome and suggested numerous other potentially bioactive proteins produced and secreted by these cells.

Fig. 2.

Fig. 2.

Secretome analysis in cultured NSPCs. (A) Heatmap of top 50 protein signals in NSPC CM by array. Data normalized to average fluorescence intensity within each slide before Z-score transformation. (M = male, F = female). (B) ELISA quantification of FASL, IGFBP-2, LIF, and VEGFA in NSPC CM (n = 3). (C) ELISA quantification of FASL, IGFBP-2, LIF, and VEGFA in NSPC cell lysate (n = 3). (D) Heatmap of emPAI values determined by LC-MS of BONCAT-enriched proteins from NSPC CM for the top 50 antibody array factors and the top 50 factors from LC-MS emPAI quantification (E). X means protein not identified in CM by LC-MS. (F) Correlation of emPAI values for proteins identified by LC-MS in NSPC CM and NSPC cell lysate. (M = male, F = female).

Given the potential for non-specific binding in the antibody array, ELISAs were used to verify and quantify select individual proteins. CM and cell lysates were generated from three different NSPC cultures, one male and two female (n=3 per line), and probed for 3 of the top 5 proteins identified in the array, VEGF, LIF, and IGFBP-2, as well as one protein that was detected very lowly on the array and was not part of the top 50 factors, FASL (Fig. 2B and C). As previously published, VEGF was detected in both NSPC CM and NSPC cell lysate (Fig. 2B and C). IGFBP-2 was also detected in CM and lysate but at over 10-fold higher levels than VEGF in the same media despite showing slightly lower intensity value than VEGF in the array (Fig. 2AC). Although LIF was the fourth highest ranked factor on the antibody array, LIF was not detected in CM or cell lysate, but lysate-derived LIF was near the threshold of detection by ELISA, suggesting low levels of LIF expression in these cells (Fig. 2B and C). Interestingly, while FASL, ranked 260th on the array, was not detected in the CM by ELISA, it was readily detected in NSPC cell lysate by ELISA, suggesting that NSPCs do synthesize FASL, but that levels in CM did not reach array or ELISA threshold (30 pg/ml) (Fig. 2B and C). These comparisons of protein levels detected in the ELISA with that suggested by the antibody array imply that this array may be frequently inaccurate at quantifying relative proteins amounts, likely due to variations in efficiency or specificity of target binding of antibodies.

2.2. Semi-quantitative LC-MS of NSPC produced proteins enables unbiased identification of NSPC secreted proteins.

To circumvent the limitations of antibody-based protein detection methods, we next pursued unbiased identification of NSPC produced proteins using LC-MS. First, we harvested cell lysates from two male and two female cultured NSPCs and used the exponentially modified protein abundance index (emPAI) derived from LC-MS spectral counts of peptides to determine the relative level of proteins (Supplemental Table 4) (Shinoda, Tomita, and Ishihama 2009; Ishihama et al. 2005). Approximately 4000 unique proteins were identified in NSPC lysates. Four of the LC-MS identified proteins, IGFBP-3, IGFBP-2, GRN, and COL18A1, were also among the top 50 secreted proteins in the array of CM (Supplemental Fig. 2). However, most of the top 50 array proteins were not detected in NSPC lysates by LC-MS. Expanding the comparison to all of the factors on the antibody array still only yields an additional eight proteins identified by LC-MS: EGFR, SPARC, ALCAM, TR10B (TRAIL2, TNFRSF10B), MFGE8, β-Catenin (CTNB1), CSK, and F3. However, secreted proteins are frequently present in only low levels intracellularly because of constant secretion to the extracellular environment. Lack of detection of a secreted protein in cell lysate therefore is an inconclusive measure of its relative abundance in the secretome.

To examine NSPC-secreted proteins, we chose to use LC-MS-based semi-quantitative analysis of NSPC CM. A major challenge of MS-based analysis of culture CM in many cell systems is high levels of exogenously-supplied proteins from serum supplements. While NSPC culture does not use animal serum, it does contain large amounts of defined protein supplements, particularly fatty acid free fraction V of bovine serum albumin. LC-MS of CM containing this supplement would have limited resolution for identifying NSPC-derived proteins because of the large amounts of supplement-derived protein. One method to circumvent this problem is to supplement-deprive the cells before collecting CM. However, deprivation protocols can dramatically alter cell physiology in vitro (Pirkmajer and Chibalin 2011). Therefore, we chose to use biorthogonal non-canonical amino acid tagging (BONCAT) (Dieterich et al. 2006) to label newly synthesized proteins in standard culture conditions and then enrich for them before LC-MS. In this method, cultures are pulsed with azidohomoalanine (AHA), a non-canonical amino acid bearing an azide moiety that is incorporated by cells in to nascent proteins instead of methionine. Presence of AHA in the amino acid chain of a protein therefore serves as a marker of a newly synthesized protein (i.e. one not derived from culture supplements). Azide groups in AHA, which are biologically rare, can undergo click chemistry reactions with similarly biologically rare alkyne groups to enable their visualization or selection (Jewett and Bertozzi 2010). In the present experiments, we pulsed cultured NSPCs with AHA and then used magnetic beads functionalized with Dibenzocyclooctyl (DBCO), which undergoes a strain promoted alkyne-azide cycloaddition reaction spontaneously. The bound proteins were then digested off of the beads before LC-MS analysis. In sum, this method allowed for enrichment of NSPC-derived proteins for their subsequent unbiased identification via LC-MS (Rothenberg et al. 2018).

While BONCAT has been successfully applied to in vivo mature neuronal populations (Alvarez-Castelao et al. 2019), it has yet to be applied to adult NSPCs. We therefore first performed several preliminary experiments to develop an AHA administration protocol that tagged proteins without altering NSPC physiology. Base NSPC growth medium contains a supraphysiological amount (>200 μM) of methionine which prevents the competitive substitution of AHA in to growing peptide chains. Thus, we cultured NSPCs with methionine-depleted growth media supplemented with fixed amounts of methionine and AHA to determine optimal concentrations that enabled maximal detection of AHA without compromising cell physiology (Supplemental Fig. 3A). NSPCs treated with varying doses of AHA and methionine were assessed for viability and proliferation by Hoechst staining and BrdU incorporation which indicated that as low as 12.5 μM methionine could maintain cell proliferation at similar levels to the standard methionine levels in NSPC culture (Supplemental Fig. 3B and C). Quantification of AHA intensity by reaction with a DBCO-IR800 dye and subsequent quantitative in-cell imaging revealed that 100 μM AHA would yield robust tagging of new proteins (Supplemental Fig. 3D). At 12.5 μM methionine and 100 μM AHA, there was no difference in the amount of VEGF protein secreted by NSPCs treated with AHA versus vehicle control, providing another piece of evidence that AHA treatment did not grossly alter cell physiology or protein secretion (Supplemental Fig. 3E).

Using the conditions defined above, one male and two female independent cultures of NSPCs were treated for 24 h with AHA or vehicle. DBCO-conjugated magnetic beads were then used to enrich for tagged proteins which were subsequently identified by LC-MS (Supplemental Table 5). Of the protein supplements provided in NSPC culture media, only albumin was detected as a non-NSPC-derived signal among bead-digested peptides. A Wilcoxon ranked sum comparison of emPAI normalized to albumin confirmed that bead enrichment of AHA tagged proteins was successful, resulting in a two-fold increase in protein capture compared to vehicle controls (Supplemental Fig. 3F). Of the top 50 proteins identified in the antibody array, five were also detected in the NSPC CM by LC-MS, namely IGFBP3, IGFBP2, IGFBP5, CCL2, and TIMP2 (Fig. 2D). However, most of the proteins from the antibody array top 50 were again absent in the LC-MS identified proteins. Expanding the analysis to the lower expressed proteins on the antibody array yielded an additional five proteins that were detected in LC-MS: Fractalkine (X3CL1), VEGFC, TIMP4, MFGE8, and IGFBP7 (IBP7). Figure 2E shows the top 50 secreted proteins identified by LC-MS in AHA-enriched samples, revealing many additional abundantly secreted proteins not assessed on the array.

To further validate production of proteins detected in CM by NSPCs, LC-MS identified proteins from CM were compared to proteins from cell lysate. Strong correlation between secreted and intracellular proteins was found (r(308) = 0.4733, p < 0.0001) with most of the proteins detected in NSPC CM also detected in NSPC cell lysate (Fig. 2F). Notably, VEGFA, which was detected in the antibody array and confirmed with ELISA, was absent not only from LC-MS of NSPC CM, but also from LC-MS of NSPC cell lysate (Fig. 2AC and Supplemental Tables 4 and 5). These data suggest that, as might be expected, LC-MS has somewhat limited sensitivity, and emphasizes that absence of a protein in LC-MS of CM does not necessarily mean a protein is not secreted in meaningful amounts. However, the relative dearth of LC-MS confirmed proteins among the highest signal proteins in the array does suggest that the array does not provide accurate estimates of relative protein amount for many of its targets.

2.3. RNA sequencing of in vitro cultured NSPCs reveals that transcriptional expression can substantially deviate from relative protein levels of secreted factors.

Extending our analysis of the secretome to the transcriptional level, we assessed relative mRNA expression via bulk RNA sequencing described in Fig 1B. Gene-length normalized transcript counts from cultured NSPCs for the genes that encode the top 50 secreted factors identified in the antibody array revealed that the majority of the array top 50 protein factors from CM were not highly transcribed at the mRNA level (Fig. 3A). Almost half of the factors were not detected in any of the samples, implying either transcript expression that is below the threshold for detection by RNAseq or false positive detection in the protein array. To evaluate the relationship between mRNA levels and protein abundance, Spearman correlation analysis of relative protein levels versus length-normalized transcript levels from cultured NSPCs for the top 50 antibody array factors was performed which showed a moderate degree of correlation overall (r(31) = 0.3904, p = 0.0299) (Fig. 3B). Though some factors, such as Igfbp3 and Igfbp2 (displayed in purple), displayed relatively high levels of both transcript and secreted protein detected in the CM array, several factors, such as Fas, Vegfa, and Lif (displayed in blue) or Col18a1 and Ifnar1 (displayed in red) respectively, showed unexpectedly low or high transcriptional expression for their ranking in the array. scRNAseq also demonstrated high and uniform expression by all clusters of cultured NSPCs for the highly secreted factors Igfbp3 and Igfbp2 (Supplemental Fig. 4A). Several of the transcripts were further investigated with real time quantitative reverse transcription-PCR (qrt-PCR) (Supplemental Fig. 4BC). For Igfbp3, Igfbp2, and Col18a1, qrt-PCR confirmed RNAseq findings of high relative transcript levels (Supplemental Fig. 4B). qrt-PCR also corroborated very low transcript levels of Fasl and Icam2, which were not detected by RNAseq. These lower levels were not due to sub-optimal primer design as positive controls amplified at levels comparable with highly transcribed genes (Supplemental Fig. 4C). For Vegf, which showed unexpectedly lower transcript levels by bulk RNAseq, qrt-PCR actually showed comparable levels of transcript with Igfbp3 and Igfbp2.

Fig. 3.

Fig. 3.

Comparison of protein abundance and relative transcript levels for in vitro NSPCs. (A) Heatmap of in vitro transcript level expression in bulk RNAseq of top 50 secreted factors identified in protein array. (B) Scatter plot of relative transcript expression in bulk RNAseq to relative protein abundance in the protein array for the top 50 array factors. Z-score of fluorescence normalized to average fluorescence intensity within each slide used as relative protein expression values. (C) Heatmap of transcript expression for top 50 secreted proteins identified by LC-MS of BONCAT-enriched NSPC CM-derived proteins. (D) Scatter plot of relative transcript expression in bulk RNAseq to relative protein abundance in LC-MS of NSPC CM. All RNA expression values are gene length normalized counts. (M = male, F = female).

Length-normalized transcript levels from bulk RNAseq of cultured NSPCs for the top 50 NSPC secreted proteins identified by LC-MS revealed better overall agreement between transcript and protein level expression than that for the array top 50, with high transcript expression being evident for the majority of the top 50 LC-MS identified proteins (Fig. 3C). To better determine whether mRNA predicts relative protein abundance, Spearman correlation analysis between all secreted NSPC factors identified by LC-MS of CM and RNAseq length-normalized transcript count from cultured NSPCs was performed. This comparison also showed a only moderate degree of correlation (r(435) = 0.3824, p < 0.0001) (Fig. 3D), implying that even with an unbiased LC-MS approach to protein identification, RNA transcript levels can deviate from relative protein amounts. For example, certain genes, such as Igfbp-3 and Tnc (displayed in blue) as well as Ckb and Eef1a1 (displayed in red) showed respectively higher or lower than expected mRNA transcript levels based on emPAI values while several others, such as Ecgr4, H1–2, H4c1, and H2ac4, were not detected at all on a transcript level (Fig 3D).

2.4. Comparison of RNAseq transcripts in cultured versus freshly isolated NSPCs reveals strong overall correlation between in vitro and in vivo NSPCs.

To explore how in vitro culturing might impact the NSPC secretome, we next compared our in vitro NSPC scRNAseq data with two previously published scRNAseq studies of in vivo adult hippocampal NSPCs (Shin et al. 2015; Hochgerner et al. 2018). In Hochgerner et al. (Hoch.), adult mouse dentate gyri were microdissected and dissociated into a single cell suspension for 10X Chromium sequencing followed by unbiased clustering analysis to assign individual cells to a cell phenotype cluster. In Shin et al., the authors dissected the dentate gyri of nestin-GFP transgenic mice and created a single cell suspension from which they manually selected GFP+ cells for sequencing on an Illumina HiSeq platform. Transcriptome data was then used to arrange cells according to pseudotime reflecting differentiation from a quiescent RGL to an activated RGL and then to an early IPC. For comparison across datasets, Hoch single cell data from radial glial like cells (Hoch. RGLs, which correspond to qRGL-NSCs), neural intermediate precursor cells (Hoch. nIPCs which correspond to aRGL-NSCs), and neuroblasts (Hoch. IPC/NBs, representing IPCs), were averaged to generate an average transcript count for each cell population. The transcript counts from Shin data were averaged between pseudotime points 0 and 0.479 to form the Shin qRGL group and between pseudotime points 0.506 and 1 to form the Shin aRGL group.

Pearson correlation analysis was performed with all transcripts that were detected above 0 in all scRNAseq datasets. This demonstrated near perfect correlation, with Pearson r values of 0.97–0.99, between clusters 0–5 in the scRNAseq dataset of cultured NSPCs (Fig. 4B). Comparison of in vitro NSPC subpopulations with Shin qRGLs revealed highest correlation (r(12504) = 0.42, p < 0.0001) with cluster 0, which we previously identified as qRGLs by expression of known qRGL markers (Fig. 1C and Supplemental Fig. 1E). However, all in vitro NSPC clusters shared comparable correlations (r(12504) = 0.54–0.56, p < 0.0001) with Shin aRGLs. Overall, these strong correlations between cultured NSPCs and in vivo RGLs seem to indicate that in vitro culture of these cells did not grossly alter the NSPC transcriptome.

Fig. 4.

Fig. 4.

Comparison of in vivo versus in vitro transcriptomes. (A) Scatter plot of relative transcript expression in bulk RNAseq versus scRNAseq of cultured NSPCs. (B) Matrix plot of relative transcript expression in in vitro NSPC clusters versus in vivo Shin qRGL, Shin aRGL, Hoch. qRGL, Hoch. aRGL, and Hoch. IPCs/NB groups. R values are displayed inside individual cells. All RNA expression represented as averaged counts for all cells within the population.

Interestingly, similar comparisons between cultured NSPC subpopulations with the Hochgerner dataset implied greater differences between in vitro and in vivo NSPCs. Pearson correlations for all six cultured NSPC subpopulations were strongest with Hoch. aRGLs (r(12781) = 0.55–0.56, p < 0.0001) and IPC/NBs (r(12781) = 0.54–0.56, p < 0.0001). All six in vitro NSPC clusters only weakly correlated to Hoch. qRGLs (r(12781) = 0.29–0.31, p < 0.0001), suggesting that cultured NSPCs as a whole acquire more of an aRGL-like phenotype in vitro. Whether the differences between comparisons of in vitro NSPCs with the two in vivo datasets reflect differences in the cells profiled (different mouse strains, housing conditions) or technical artefact of different scRNAseq platforms is unclear. Collectively, the comparisons between the Shin and Hochgerner datasets seem to corroborate the identities of the populations described in those studies. Hoch. qRGLs strongly correlated with Shin qRGLs (r(11493) = 0.44, p < 0.0001) while Hoch. aRGLs (r(11493) = 0.53, p < 0.0001) and IPC/NBs (r(11493) = 0.46, p < 0.0001) correlated more strongly with Shin aRGLs.

2.5. The NSPC transcriptome frequently fails to accurately predict the NSPC secretome.

To determine the utility of RNAseq in predicting the NSPC secretome, we performed Gene Ontology (GO) analysis of all transcripts detected above zero in the bulk RNAseq of in vitro NSPCs and identified over 600 genes with transcript levels greater than zero that encode proteins located in the extracellular region (Supplemental Table 6). Of these genes, 72 were detected above zero at the protein level in LC-MS of in vitro NSPC CM and 55 were found in LC-MS of in vitro NSPC lysate (Supplemental Table 6). Comparison of relative RNA transcript levels with relative protein levels showed that, in general, genes with higher transcript counts were more likely to show higher protein abundance in both the lysate (r(887) = 0.3975, p < 0.0001) and CM (r(887) = 0.3881, p < 0.0001) (Fig. 5A). However, there were numerous genes with high transcriptional expression, but little to no protein level expression in CM or lysate. If RNA expression were being used to predict the secretome, these genes would represent a group that would be falsely identified as major components of the NSPC secretome. Focusing on proteins that were not present in CM revealed several proteins that had high gene level expression and high intracellular protein levels (Manf and Sod1, displayed in blue), suggesting high protein production but absence of secretion (Fig. 5B). In addition, several proteins were also found that had high gene expression but low intracellular protein levels (e.g. Itm2c and, displayed in red), suggesting lack of translation of these transcripts (Fig. 5B). All together, these data suggest that using RNA expression from high throughput techniques like RNAseq to prospectively identify major components of the secretome may lead to false positives due to translational and secretion-level regulation.

Fig. 5.

Fig. 5.

Correlation of transcript level with protein abundance for GO term identified extracellular proteins from bulk RNAseq of cultured NSPCs. (A) Scatter plot of relative protein abundance determined by LC-MS of BONCAT-enriched NSPC CM-derived proteins and of lysate-derived proteins relative to transcript expression for genes encoding extracellular proteins. (B) Scatter plot of relative protein abundance determined by LC-MS of cultured NSPC lysate relative to transcript expression for genes encoding extracellular proteins that are not detected in NSPC CM. All RNA expression values are gene length normalized counts.

3. Discussion

Over the past decade, stem cell secretomes have been investigated for their potential therapeutic applications to various neurologic disorders (Drago et al. 2013; Baraniak and McDevitt 2010; Liang et al. 2014). The cytokines, chemokines, and growth factors that comprise the NSPC secretome have been thus far identified individually or in limited combinations with traditional methods of protein analysis such as immunohistochemistry, western blotting, and ELISA (Skalnikova et al. 2011). In other tissue stem cells, broader characterization of secreted proteins has been achieved with array based methods examining isolated stem cell populations maintained in vitro (Skalnikova et al. 2011). More recently, in vivo stem cell profiling with low cell and scRNAseq has emerged as a proxy for untargeted protein level analysis in small populations like NPSCs that do not yield sufficient protein for high-throughput translational-level analysis (Artegiani et al. 2017; Hochgerner et al. 2018; Shin et al. 2015). Cumulatively, these methods have provided several informative pieces of the puzzle. Our findings at the transcriptional level as well as the protein level in vitro provide a first attempt at a comprehensive analysis of the NSPC secretome, and, in the process, highlight limitations to current approaches.

Using a commercially-available array of over 300 preselected proteins, we probed the CM of cultured NSPCs to generate a list of highly secreted factors, as is common for studies of secretome profiling (Skalnikova et al. 2011). Unexpectedly, though, further scrutiny of selected “top” targets by ELISA and an unbiased screen for secreted factors via LC-MS based approaches revealed minimal corroboration of the array results. For example, quantification by ELISA of VEGFA and IGFBP-2 revealed over 10 fold more IGFBP-2 than VEGFA in contrast to the array fluorescence signal which ranked VEGFA slightly higher than IGFBP-2. LC-MS analysis of cell lysate and CM confirmed the ELISA results, showing high levels of IGFBP-2 while VEGFA did not reach the detection limit of this method. More broadly, while most of the top 50 proteins by array were not detected by LC-MS, proteins from near the bottom of the array ranking, such as Fractalkine (X3CL1), VEGFC, and MFGE8, were detected by LC-MS. These data suggest that the fluorescence intensity values of the array used in the present work do not accurately represent relative protein abundance.

Ideally, factors identified in an antibody-based screen would undergo additional validation with methods including ELISA or LC-MS as presented here. However, while ELISA and LC-MS-based methods for protein quantification likely provide more accurate protein identification and quantification, they also have limitations.

First, LC-MS has a relatively high minimum threshold required for protein detection. The provision of exogenous proteins in cell culture media, even when these proteins are known, can reduce sensitivity for identifying cell-derived proteins. We used recently-developed protocols for enriching the cell-derived secretome via BONCAT (Mahdavi et al. 2016; Liu et al. 2017; Elliott, Bianco, and Chin 2014) to boost sensitivity without supplement-depriving cultured NSPCs. BONCAT has been previously shown to not alter the proteome or secretome in detectable ways (Mahdavi et al. 2016; Liu et al. 2017; Dieterich et al. 2006) and we also confirmed that cultured NSPCs showed no overt signs of proteomic changes due to incorporation of non-canonical amino acids in the nascent proteins. However, it is still possible that BONCAT alters the proteome of NSPCs and this possibility should be considered when evaluating data from BONCAT-enriched proteomes. In addition, even with BONCAT enrichment, LC-MS showed somewhat low sensitivity. For example, VEGFA was readily detected in CM and cell lysate by ELISA, but it was not detected in BONCAT enriched LC-MS of CM. Meeting the threshold level of detection for LC-MS likely excluded detection of other NSPC-produced factors that may have biologically relevant functions.

In contrast to LC-MS, ELISAs are frequently capable of detecting picogram amounts of protein in CM. However, they are only able to assess one protein at a time. Verifying a broad secretome screen via ELISA may frequently be impractical due to the time and cost of numerous ELISAs. Additionally, given how few of the top array factors were confirmed by LC-MS, our data seems to suggest that pursuing numerous validations of top array factors by ELISA may not be advisable. These respective limitations should be considered when choosing a method for proteomic profiling of the secretome and interpreting its results.

We also examined the NSPC secretome at the transcriptional level via RNAseq. Bulk and single cell RNAseq data confirmed the identity of NSPC cultures as primarily quiescent and activated NSCs in various stages of the cell cycle. Overall correlation between gene-length normalized mRNA transcript counts of cultured NSPCs and relative protein abundance in cultured NSPC CM by LC-MS was only moderate (Fig. 3D), suggesting that transcriptional expression is not a direct measure of secreted protein abundance. Furthermore, attempting to prospectively predict highly secreted proteins from the transcriptional expression of genes coding for extracellularly located proteins was less reliable. Here, we found a subpopulation of factors that were high in mRNA abundance, but low in abundance or completely absent from NSPC CM at the protein level. Some of these genes appeared to be regulated at the translational level as their protein amounts were low in cell lysate while others appeared to be regulated at the secretion level as their protein abundance intracellularly was high despite begin absent from CM. These disparities emphasize the importance of involving protein-level analyses to transcript-level analyses when identifying secretome components and suggest a potential pitfall of defining a secretome based on transcriptional data.

Significant changes to cell physiology secondary to culturing have been reported for other stem cell populations (Binato et al. 2013; Duggal et al. 2009; Duggal and Brinchmann 2011; Wernly et al. 2017; Shahdadfar et al. 2005). In fact, cultured NSCs isolated from the SVZ displayed important differences in transcription of inflammatory cytokines compared to their in vivo counterparts (Dulken et al. 2017). Comparison of the present in vitro scRNAseq dataset with two previously published in vivo DG NSPC scRNAseq datasets showed moderate to strong correlations in gene expression (Shin et al. 2015; Hochgerner et al. 2018). These correlations suggest overall global agreement in relative transcriptional profiles, and support the utility of adult DG NSPC cultures as a model of their in vivo counterpart. However, future analyses of specific gene expression patterns between these datasets are required to determine whether the differences that do exist between datasets reflect true differences in cell physiology. Study of both cultured and acutely isolated stem cells is particularly critical for the development of effective NSPC-based therapies as current clinical trials use cultured neural stem cell lines and many preclinical models use NSPCs with varying amounts of in vitro processing (Mazzini et al. 2019; Ottoboni, Merlini, and Martino 2017; Mendes-Pinheiro et al. 2018; Chandanala et al. 2014).

In conclusion, we provide a multi-level characterization of the NSPC secretome, in the process, identifying potentially important differences between protein and RNA expression in NSPCs and highlighting limitations in current methods of secretome profiling. Combined, our data suggest that no one method or level of analysis is sufficient for characterizing the NSPC secretome and we propose that the various proteins identified here as highly expressed in different platforms represent a putative NSPC secretome that requires subsequent validation. As stem cell-based therapies are currently being developed with both cultured and endogenous cells, our findings suggest that the optimal approach is a multifaceted one that includes unbiased global proteome analysis in conjunction with transcriptome analysis for the comprehensive characterization of in vitro and in vivo NSPCs.

4. Experimental Procedures

4.1. Animals

Male and female C57/Bl6 mice (Jackson) aged 8–10 weeks were group housed (up to 5 per cage) in standard ventilated cages with food and water ad libitum on a 12 hour light cycle. Animals were anesthetized with intraperitoneal injections of 87.5 mg/kg ketamine / 12.5 mg/kg xylazine before perfusion and harvest of brains for primary cell derivations. This study was approved by the Institutional Animal Care and Use Committee (IACUC) at the Ohio State University.

4.2. Cell Culture

NSPCs were isolated from adult DGs of C57/Bl6 mice as described in (Babu et al. 2011). NSPCs were cultured on poly-D-lysine (Sigma) and laminin (Invitrogen) coated plates in Neurobasal A media (Invitrogen) with 1× B27 supplement without vitamin A (Gibco), 1× glutamax (Invitrogen) and 20 ng/ml each of EGF and FGF2 (Peprotech). All cells used were between passage five and 15. Two separate lines were used in experiments, one from 4 pooled C57/Bl6 male mice and one from 4 pooled C57/Bl6 female mice. No inherent differences in morphology or proliferation between NSPCs isolated from males and females were found. Both lines were verified to be mycoplasma-free and to produce neurons and glia upon culture in differentiation conditions. NSPCs were differentiated according to the growth factor withdrawal protocol described in Babu et al. 2011.

4.3. Immunofluorescence

NSPCs were cultured in chamber slides under maintenance or differentiation conditions described above. Cells were fixed with 4% paraformaldehyde (PFA) then rinsed in 1× phosphate buffered saline (PBS) before blocking with 1% normal donkey serum (Jackson) and 0.3% Triton X-100 in PBS for 1h at room temperature. Cells were incubated with primary antibodies (Supplemental Table 7) overnight at 4°C in blocking solution on an orbital shaker. The next day, cells were washed with PBS and incubated with fluorescently conjugated secondary antibodies diluted in blocking solution (Supplemental Table 7) for 2h at room temperature. 10 minute incubation with Hoechst 33342 (Fisher, 1:2000) was then used to label DNA in nuclei. After washing, chambers were removed from slides and cells were coverslipped with ProLong Gold anti-fade solution (Molecular Probes) before imaging on a Zeiss Axio Observer Z.1 with apotome digital imaging system and Axiocam 506 monochrome camera (Zeiss).

For BONCAT optimization studies, NSPCs were cultured in 96 well plates. At 80% confluence, NSPC growth media was replaced with methionine-depleted neurobasal A (Gibco) containing 1× B27 supplement without vitamin A (Gibco), 1× glutamax (Invitrogen), 20 ng/ml each of EGF and FGF2 (Peprotech) for 30 min. After 30 min of methionine washout, growth media containing 12.5 μM methionine (Gibco), 1× B27 supplement without vitamin A (Gibco), 1× glutamax (Invitrogen), 20 ng/ml each of EGF and FGF2 (Peprotech) and 100 μM AHA (Click Chemistry Tools) or water vehicle was added to NSPCs which were incubated for 24 h at 37°C and 5% CO2. After 24 h, 20 μM BrdU was added to cells for 2 h prior to fixation. Cells were stained in 96 well format for BrdU and Hoechst 33342 or DBCO IR800 (Supplemental Table 7).

For BrdU, cells were fixed with 4% PFA for 10 min and blocked with 1% normal donkey serum (Jackson) and 0.3% Triton X-100 in PBS for 1h at room temperature before a 30 min antigen retrieval with 2N hydrochloric acid a 37°C. Cells were then incubated with anti-BrdU antibody overnight at 4°C. After 3 washes with PBS, cells were incubated with secondary antibody for 2h at room temperature, protected from light. Hoechst 33342 was added for the last 10 min of secondary antibody incubation. Cells were washed three times with PBS before imaging on the Zeiss Axio Observer Z.1.

For DBCO IR800, AHA-treated NSPCs were fixed with ice cold methanol and washed with PBS three times before treatment with iodoacetamide for 90 min at room temperature, protected from light.12 μM DBCO IR800 was spiked in to the wells and the plate was incubated at room temperature for 30 min, protected from light. Cells were washed with PBS three times before aspirating all buffer and imaging the plate on LICOR Odyssey.

4.4. Cytokine antibody array

Conditioned media was generated from three separate cultures of NSPCs, one male and two female, at 80% confluence. After 48 hours of culture, media was collected and centrifuged at 1000g for 10 min to remove large debris. For sample normalization, NSPCs for each corresponding conditioned media sample were also harvested with accutase (Invitrogen) and total protein was quantified with a BCA protein assay kit (Pierce) per manufacturer recommendations. Preparation and staining of slides were completed per manufacturer recommendations with the following modifications (RayBiotech L308 cytokine antibody array). The second dialysis step both before and after labeling of samples with biotin were conducted overnight at 4°C. Incubation of slides with biotin-labeled samples was also conducted overnight at 4°C. Incubation with Cy3-conjugated streptavidin was conducted for two hours at room temperature. After completion of the protocol, slides were completely dried before they were stored at −20°C in the 30 mL centrifuge tube provided by the manufacturer until processing. Slides were scanned by RayBiotech and raw data was analyzed according to manufacturer instructions using the RayBio Analysis Tool Software.

4.5. ELISA

Conditioned media was generated after a 24 hour incubation of complete growth media with NSPCs between passages 5 and 15 at 80% confluence. After collection of media, cells were then lysed with RIPA buffer (Thermo) containing Halt protease inhibitor cocktail (Thermo) and cell lysate was stored at −20°C. Conditioned media samples were centrifuged to remove debris as above, aliquoted, and stored at −20°C until use. VEGF, IGFBP-2, LIF, and FASL ELISAs (all R&D Systems) were performed per manufacturer instructions. All standards were created in NSPC growth media for conditioned media samples and RIPA buffer for cell lysates. Microplates were read with an Epoch microplate reader (Biotek) at 450 nm wavelength.

4.6. Mass Spectrometry

For LC-MS of NSPC cell lysate, NSPCs were harvested with accutase (Invitrogen) and washed with Hank’s balanced salt solution (HBSS) before processing by the Ohio State University CCIC Mass Spectrometry and Proteomics Facility as described below.

LC-MS of NSPC BONCAT enriched conditioned media-derived proteins was performed according to a modification of the protocol of Dieterich et al 2006. CM containing AHA-tagged proteins was generated with male and female NSPCs between passage five and 15. At 80% confluence, NSPCs in 10 cm dishes between passage 5 and 15 were methionine depleted for 30 min by incubation with neurobasal A without methionine (Gibco), 1× B27 supplement without vitamin A (Gibco), 1× glutamax (Invitrogen) and 20 ng/ml each of EGF and FGF2 (Peprotech). After 30 min, media was replaced with 5 ml neurobasal A containing 12.5 μM methionine (Gibco), 1× B27 supplement without vitamin A (Gibco), 1× glutamax (Invitrogen), 20 ng/ml each of EGF and FGF2 (Peprotech) and 100 μM AHA (Click Chemistry Tools) or water vehicle. After 24 hrs, conditioned media was collected and centrifuged at 1000g for 10 min to remove large debris. Conditioned media was then concentrated with 3kDa Amicon Ultra filters according to manufacturer instructions (Millipore) to ~ 250 μl total volume. PBS was then added to the remaining concentrate up to the maximum capacity of the filter unit to dilute free AHA followed by a second round of concentration. The final concentrate was mixed with an equal volume of water with protease inhibitors (Roche) and sonicated five times with one second pulses at 50% amplitude (Fisher). Samples were contrifuged at 15,000g for 5 min and supernatants were treated with 50 μM iodoacetamide (Pierce) for 90 min in the dark. 100 μl of DBCO magnetic beads per sample were washed with 100 μl PBS 3 times before being resuspended in iodoacetamide-treated conditioned media concentrates. Beads were rotated end-over-end for 16–18 hrs. Beads were then washed with 400 μl of 0.8% SDS in PBS 8 times, 400 μl of 8 M urea eight times, and 400 μl of 20% acetonitrile eight times before transfer to the Ohio State University CCIC Mass Spectrometry and Proteomics Facility.

In preparation for protein digest, beads were washed with 50 μl of 50 mM ammonium bicarbonate three times. Each time, the supernatants were kept and pooled. After the third wash, 5 μL of DTT (5 μg/μL in50 mM ammonium bicarbonate) was added and the samples were incubated at 56°C for 15 min. After the incubation, 5uL of iodoacetamide (15 mg/ml in 50mM ammonium bicarbonate) was added and the sample was kept in dark at room temperature for 30 min. Sequencing grade-modified trypsin (Promega, Madison WI) prepared in 50 mM ammonium bicarbonate was added to the sample with an estimation of 1:20 /1:100 enzyme-substrate ratio and the reaction was carried on at 37°C for overnight. The reaction was quenched the next morning by adding acetic acid for acidification. Supernatant was then concentrated for LC/MSMS analysis with the Thermo Scientific Orbitrap Fusion mass spectrometer equipped with an EASY-Spray™ Sources operated in positive ion mode. Samples (6.4μL) were separated on an easy spray nano column (PepmapTM RSLC, C18 3μ 100A, 75μm X150mm Thermo Scientific) using a 2D RSLC HPLC system from Thermo Scientific. Each sample was injected into the μ-Precolumn Cartridge (Thermo Scientific) and desalted with 0.1% formic acid in water for 5 minutes. The injector port was then switched to inject and the peptides were eluted off of the trap onto the column. Mobile phase A was 0.1% formic acid in water and acetonitrile (with 0.1% formic acid) was used as mobile phase B. Flow rate was set at 300nL/min. A 2hr gradient was used: mobile phase B was increased from 2% to 20% in 105 min and then increased from 20–32% in 10 min and again from 32–95% in 1 min and then kept at 95% for another 4 min before being brought back quickly to 2% in 1 min. The column was equilibrated at 2% of mobile phase B (or 98% A) for 15 min before the next sample injection.

MS/MS data was acquired with a spray voltage of 1.6 KV and a capillary temperature of 305°C is used. The scan sequence of the mass spectrometer was based on the preview mode data dependent TopSpeed™ method: the analysis was programmed for a full scan recorded between m/z 375–1500 and a MS/MS scan to generate product ion spectra to determine amino acid sequence in consecutive scans starting from the most abundant peaks in the spectrum in the next 3 seconds. To achieve high mass accuracy MS determination, the full scan was performed at FT mode and the resolution was set at 120,000 with internal mass calibration. The AGC Target ion number for FT full scan was set at 4 × 105 ions, maximum ion injection time was set at 50 ms and micro scan number was set at 1. MSn was performed using HCD in ion trap mode to ensure the highest signal intensity of MSn spectra. The HCD collision energy was set at 32%. The AGC Target ion number for ion trap MSn scan was set at 3.0E4 ions, maximum ion injection time was set at 35 ms and micro scan number was set at 1. Dynamic exclusion is enabled with a repeat count of 1 within 60s and a low mass width and high mass width of 10ppm.

Sequence information from the MS/MS data was processed by converting the .raw files into a merged file (.mgf) using MSConvert (ProteoWizard). The resulting mgf files were searched against the most recent Uniprot databases using Mascot Daemon by Matrix Science version 2.5.1 (Boston, MA). A decoy database was also searched to determine the false discovery rate (FDR) and peptides were filtered according at 1% FDR. Proteins identified with at least two unique peptides were considered as reliable identification. Any modified peptides are manually checked for validation.

4.7. Bulk RNAseq RNA isolation, cDNA library construction, and sequencing

Approximately 30,000 cells from two female and two male adult NSPCs cultures were harvested with accutase (Stem Cell Technologies) and washed with PBS before RNA isolation with the Clontech Nucleospin RNA XS Plus isolation kit (Takara 740990.10) per manufacturer protocol. RNA was also isolated from whole DGs isolated from one male and one female C57/Bl6 mouse with the same kit. RNA quality and quantity was assessed with a Qubit RNA HS assay kit (Invitrogen). All cultured samples used had a RIN value of 10 while whole DG samples had RIN values over 8. Libraries were generated with the NEBNext Ultra II Directional RNA Library prep kit (New England Biolabs) for the whole DGs and the Clontech SMART-Seq HT (Takara) kit for cultured NSPCs. Purified library products were then used in HiSeq 4000 paired-end sequencing (Illumina) to a depth of 15 – 20 million 2×150 bp clusters.

4.8. Bulk RNAseq analysis

Individual FASTQ files were trimmed for adapter sequences and filtered for a minimum quality score of Q20 using AdapterRemoval v2.2.0. Preliminary alignment using HISAT2 v2.0.6 was performed to a composite reference of rRNA, mtDNA, and PhiX bacteriophage sequences obtained from NCBI RefSeq. Reads aligning to these references were excluded in downstream analyses. Primary alignment was performed against the mouse genome reference GRCm38p4 using HISAT2. Gene expression values for genes described by the GENCODE Gene Transfer Format (GTF) release M14 (mouse) were quantified using the featureCounts tool of the Subread package v1.5.1 58 in stranded mode.

4.9. scRNA sequencing and analysis

One male and two female NSPCs between passage 7 and 12 were harvested from adherent culture. Cells were resuspended and washed in HBSS before making a mixed sample with equal numbers from each NSPC culture for scRNAseq. 10X Genomics 3’ RNA-seq library was sequenced using paired-end 150bp approach on an Illumina HiSeq 4000 sequencer. CellRanger v3.0.2 (Zheng et al. 2017) was used to demultiplex, align, and deduplicate sequencing reads in BCL files. Single-cell data in feature-barcode matrices were then processed using Seurat v3.0.1’s default pipeline (Butler et al. 2018) to identify unsupervised cell clusters and generate a t-Distributed Stochastic Neighbor Embedding (t-SNE) plot. Seurat’s feature expression analysis was used to visualize genes markers known to be expressed in cell populations displayed in the t-SNE plot.

4.10. Quantitative rt-PCR

For qrt-PCR, all RNA was isolated and DNase treated with the BioRad Aurum™ Total RNA Mini Kit. In vitro NSPCs were lysed in culture plates and then transferred to spin columns provided by the BioRad Aurum™ kit. For the positive controls, a spleen was extracted from an adult C57B/l6 mouse and minced before lysis with lysis buffer from the Bio Rad Aurum™ kit. Isolated RNA was quantified and assessed for quality using the BioTek Epoch Microplate Spectrophotometer. cDNA was synthesized with the BioRad iScript™ cDNA Synthesis Kit in the ThermoFisher Applied Biosystems 2720 Thermal Cycler. qrtPCR was performed in the Bio Rad CFX96 Touch Real-Time PCR Detection System with BioRad SsoAdvanced Universal SYBR Green Supermix and primers listed in Supplemental Table 7. Ct values were determined from raw amplification data using Real-time PCR Miner software (Zhao and Fernald 2005). The PCR Miner Ct output was converted to fold change relative to the Ct value for the housekeeping gene sdha.

4.11. Statistics

Fluorescence intensity for each protein in the protein array was normalized to the average fluorescence intensity within each slide. Z-scores were calculated in Microsoft Excel and a heatmap of top 50 secreted factors was generated with Prism Graphpad software. For Spearman correlation with RNAseq data, fluorescence values normalized to the average fluorescence intensity within each slide were calculated in Microsoft Excel before statistical analysis and graphical representation with Prism Graphpad software.

For all ELISAs, absolute protein concentrations for each sample were determined based on the standard curve and graphically represented using Prism Graphpad software.

For RNAseq analysis, published data was retrieved in Excel format from (Shin et al. 2015) and (Hochgerner et al. 2018). scRNAseq counts for each gene were averaged to generate a representative count for each population. Shin qRGLs were averaged from pseudotime point 0 to 0.479. Shin aRGLs were averaged from pseudotime point 0.506 to 1. Pearson correlations were completed between the cultured NSPC clusters, Shin qRGL, Shin aRGL, Hoch. qRGL, Hoch aRGL, and Hoch IPC/NB scRNAseq counts averaged over cell type for each population. All correlation statistics (α = 0.05) were completed for gene length normalized counts for bulk RNAseq, emPAI values for LC-MS data, or averaged counts for scRNAseq with Prism Graphpad software.

Supplementary Material

1
2
NIHMS1576778-supplement-2.pptx (1,023.1KB, pptx)
3
4
5
6
7
8
9
10
11
12

Highlights.

  • The neural stem and progenitor cell (NSPC) secretome is currently undefined.

  • In vitro NSPC intracellular and secreted proteins were assessed by array and LC-MS.

  • Gene expression does not reliably predict secreted protein abundance in vitro.

  • Gene expression profiles of in vitro and in vivo NSPCs strongly correlate.

  • Combined protein and RNA level analysis of in vivo and in vitro NSPCs is needed.

Acknowledgements

This work was supported by R00NS089938 to EDK from the NIH/NINDS, and IOS-1923094 to EDK from NSF.

Footnotes

4.12.

Data Availability

Processed reads for NSPC bulk RNAseq data are provided as supplemental table 1. Upon publication, raw data files for both the bulk RNAseq and scRNAseq datasets will be publicly available in GEO (GSE138381).

Declaration of interest

All authors declare that there is no actual or potential conflict of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Beatriz Alvarez-Castelao, Schanzenbächer Christoph T., Langer Julian D., and Schuman Erin M.. 2019. “Cell-Type-Specific Metabolic Labeling, Detection and Identification of Nascent Proteomes in Vivo.” Nature Protocols 14 (2): 556–75. 10.1038/s41596-018-0106-6. [DOI] [PubMed] [Google Scholar]
  2. Andres Robert H., Horie Nobutaka, Slikker William, Hadar Keren-Gill Ke Zhan, Sun Guohua, Manley Nathan C., et al. 2011. “Human Neural Stem Cells Enhance Structural Plasticity and Axonal Transport in the Ischaemic Brain.” Brain 134 (6): 1777–89. 10.1093/brain/awr094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Artegiani Benedetta, Lyubimova Anna, Muraro Mauro, van Es Johan H., van Oudenaarden Alexander, and Clevers Hans. 2017. “A Single-Cell RNA Sequencing Study Reveals Cellular and Molecular Dynamics of the Hippocampal Neurogenic Niche.” Cell Reports 21 (11): 3271–84. 10.1016/j.celrep.2017.11.050. [DOI] [PubMed] [Google Scholar]
  4. Babu Harish, Claasen Jan-Hendrik, Kannan Suresh, Annette E Rünker Theo Palmer, and Kempermann Gerd. 2011. “A Protocol for Isolation and Enriched Monolayer Cultivation of Neural Precursor Cells from Mouse Dentate Gyrus.” Frontiers in Neuroscience 5: 89 10.3389/fnins.2011.00089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bacigaluppi Marco, Sferruzza Giacomo, Butti Erica, Ottoboni Linda, and Martino Gianvito. 2020. “Endogenous Neural Precursor Cells in Health and Disease.” Brain Research 1730 (March): 146619. 10.1016/J.BRAINRES.2019.146619. [DOI] [PubMed] [Google Scholar]
  6. Baraniak Priya R., and McDevitt Todd C.. 2010. “Stem Cell Paracrine Actions and Tissue Regeneration.” Regenerative Medicine 5 (1): 121–43. 10.2217/rme.09.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barkho Basam Z, Hongjun Song, James B Aimone, Richard D Smrt, Tomoko Kuwabara, Kinichi Nakashima, Fred H Gage, and Xinyu Zhao. 2006. “Identification of Astrocyte-Expressed Factors That Modulate Neural Stem/Progenitor Cell Differentiation.” Stem Cells and Development 15 (3): 407–21. 10.1089/scd.2006.15.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Besse Florence, and Ephrussi Anne. 2008. “Translational Control of Localized MRNAs: Restricting Protein Synthesis in Space and Time” Nature Reviews Molecular Cell Biology. Nature Publishing Group; 10.1038/nrm2548. [DOI] [PubMed] [Google Scholar]
  9. Binato R, de Souza Fernandez T, Lazzarotto-Silva C, Du Rocher B, Mencalha A, Pizzatti L, Bouzas LF, and Abdelhay E. 2013. “Stability of Human Mesenchymal Stem Cells during in Vitro Culture: Considerations for Cell Therapy.” Cell Proliferation 46 (1): 10–22. 10.1111/cpr.12002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Butler Andrew, Hoffman Paul, Smibert Peter, Papalexi Efthymia, and Satija Rahul. 2018. “Integrating Single-Cell Transcriptomic Data across Different Conditions, Technologies, and Species.” Nature Biotechnology. 10.1038/nbt.4096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chandanala Shashank, Harishchandra Prasad Ys Chiatra Venugopal, and Dhanushkodi Anandh. 2014. “Stem Cells Based Therapy for Temporal Lobe Epilepsy.” J Clin Biomed Sci. Vol. 4 www.jcbsonline.ac.in. [Google Scholar]
  12. Dieterich Daniela C., Link A. James, Graumann Johannes, Tirrell David A., and Schuman Erin M.. 2006. “Selective Identification of Newly Synthesized Proteins in Mammalian Cells Using Bioorthogonal Noncanonical Amino Acid Tagging (BONCAT).” Proceedings of the National Academy of Sciences of the United States of America 103 (25): 9482–87. 10.1073/pnas.0601637103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drago Denise, Cossetti Chiara, Iraci Nunzio, Gaude Edoardo, Musco Giovanna, Bachi Angela, and Pluchino Stefano. 2013. “The Stem Cell Secretome and Its Role in Brain Repair.” Biochimie 95 (12): 2271–85. 10.1016/j.biochi.2013.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Duggal Shivali, and Brinchmann Jan E.. 2011. “Importance of Serum Source for the in Vitro Replicative Senescence of Human Bone Marrow Derived Mesenchymal Stem Cells.” Journal of Cellular Physiology 226 (11): 2908–15. 10.1002/jcp.22637. [DOI] [PubMed] [Google Scholar]
  15. Duggal Shivali, Frønsdal Katrine B., Szöke Krisztina, Shahdadfar Aboulghassem, Melvik Jan Egil, and Brinchmann Jan E.. 2009. “Phenotype and Gene Expression of Human Mesenchymal Stem Cells in Alginate Scaffolds.” Tissue Engineering Part A 15 (7): 1763–73. 10.1089/ten.tea.2008.0306. [DOI] [PubMed] [Google Scholar]
  16. Dulken Ben W., Leeman Dena S., Boutet Stéphane C., Hebestreit Katja, and Brunet Anne. 2017. “Single-Cell Transcriptomic Analysis Defines Heterogeneity and Transcriptional Dynamics in the Adult Neural Stem Cell Lineage.” Cell Reports 18 (3): 777–90. 10.1016/j.celrep.2016.12.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Durr Eberhard, Yu Jingyi, Krasinska Karolina M., Carver Lucy A., Yates John R., Testa Jacqueline E., Oh Phil, and Schnitzer Jan E.. 2004. “Direct Proteomic Mapping of the Lung Microvascular Endothelial Cell Surface in Vivo and in Cell Culture.” Nature Biotechnology 22 (8): 985–92. 10.1038/nbt993. [DOI] [PubMed] [Google Scholar]
  18. Elliott Thomas S, Ambra Bianco, and Jason W Chin. 2014. “Genetic Code Expansion and Bioorthogonal Labelling Enables Cell Specific Proteomics in an Animal.” Current Opinion in Chemical Biology 21 (August): 154–60. 10.1016/j.cbpa.2014.07.001. [DOI] [PubMed] [Google Scholar]
  19. Gage Fred H., and Temple Sally. 2013. “Neural Stem Cells: Generating and Regenerating the Brain.” Neuron 80 (3): 588–601. 10.1016/j.neuron.2013.10.037. [DOI] [PubMed] [Google Scholar]
  20. Hochgerner Hannah, Zeisel Amit, Peter Lönnerberg, and Sten Linnarsson. 2018. “Conserved Properties of Dentate Gyrus Neurogenesis across Postnatal Development Revealed by Single-Cell RNA Sequencing.” Nature Neuroscience 21 (2): 290–99. 10.1038/s41593-017-0056-2. [DOI] [PubMed] [Google Scholar]
  21. Ishihama Yasushi, Yoshiya Oda, Tsuyoshi Tabata, Toshitaka Sato, Takeshi Nagasu, Juri Rappsilber, and Matthias Mann. 2005. “Exponentially Modified Protein Abundance Index (EmPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein.” Molecular and Cellular Proteomics 4 (9): 1265–72. 10.1074/mcp.M500061-MCP200. [DOI] [PubMed] [Google Scholar]
  22. Jewett John C., and Bertozzi Carolyn R.. 2010. “Cu-Free Click Cycloaddition Reactions in Chemical Biology.” Chemical Society Reviews 39 (4): 1272 10.1039/b901970g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ji Rui, Meng Lingbin, Jiang Xin, Naresh Kumar Cvm Jixiang Ding, Li Qiutang, and Lu Qingxian. 2014. “TAM Receptors Support Neural Stem Cell Survival, Proliferation and Neuronal Differentiation.” PloS One 9 (12): e115140. 10.1371/journal.pone.0115140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kalluri Haviryaji S. G., and Dempsey Robert J.. 2011. “IGFBP-3 Inhibits the Proliferation of Neural Progenitor Cells.” Neurochemical Research 36 (3): 406–11. 10.1007/s11064-010-0349-2. [DOI] [PubMed] [Google Scholar]
  25. Kirby Elizabeth D., Kuwahara Akela A., Messer Reanna L., and Wyss-Coray Tony. 2015. “Adult Hippocampal Neural Stem and Progenitor Cells Regulate the Neurogenic Niche by Secreting VEGF.” Proceedings of the National Academy of Sciences 112 (13): 4128–33. 10.1073/pnas.1422448112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Knight Julia C, Eugene L Scharf, and Yang Mao-Draayer. 2010. “Fas Activation Increases Neural Progenitor Cell Survival.” Journal of Neuroscience Research 88 (4): 746–57. 10.1002/jnr.22253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee Eun Mi, Hurh Sunghoon, Cho Bumrae, Oh Kook-Hwan, Seung U Kim, Charles D Surh, Jonathan Sprent, Jaeseok Yang, Jae Young Kim, and Curie Ahn. 2013. “CD70-CD27 Ligation between Neural Stem Cells and CD4+ T Cells Induces Fas-FasL-Mediated T-Cell Death.” Stem Cell Research & Therapy 4 (3): 56 10.1186/scrt206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liang Xiaoting, Ding Yue, Zhang Yuelin, Tse Hung-Fat, and Lian Qizhou. 2014. “Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives.” Cell Transplantation 23 (9): 1045–59. 10.3727/096368913X667709. [DOI] [PubMed] [Google Scholar]
  29. Lipshitz Howard D., Claycomb Julie M., and Smibert Craig A.. 2017. “Post-Transcriptional Regulation of Gene Expression.” Methods 126 (August): 1–2. 10.1016/J.YMETH.2017.08.007. [DOI] [PubMed] [Google Scholar]
  30. Liu Yan, Conboy Michael J., Mehdipour Melod, Liu Yutong, Tran Thanhtra P., Blotnick Aaron, Rajan Prasanna, Santos Thalie Cavalcante, and Irina M. Conboy. 2017. “Application of Bio-Orthogonal Proteome Labeling to Cell Transplantation and Heterochronic Parabiosis.” Nature Communications 8 (1): 643 10.1038/s41467-017-00698-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mahdavi Alborz, Hamblin Graham D., Jindal Granton A., Bagert John D., Dong Cathy, Sweredoski Michael J., Hess Sonja, Schuman Erin M., and Tirrell David A.. 2016. “Engineered Aminoacyl-TRNA Synthetase for Cell-Selective Analysis of Mammalian Protein Synthesis.” Journal of the American Chemical Society 138 (13): 4278–81. 10.1021/jacs.5b08980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mazzini Letizia, Gelati Maurizio, Daniela Celeste Profico Gianni Sorarù, Ferrari Daniela, Copetti Massimiliano, Muzi Gianmarco, et al. 2019. “Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long‐Term Outcome.” STEM CELLS Translational Medicine 8 (9): sctm.18–0154. 10.1002/sctm.18-0154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mendes-Pinheiro Bárbara, Teixeira Fábio G., Anjo Sandra I., Manadas Bruno, Behie Leo A., and Salgado António J.. 2018. “Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson’s Disease.” Stem Cells Translational Medicine 7 (11): 829–38. 10.1002/sctm.18-0009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ming Guo-li, and Song Hongjun. 2011. “Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions.” Neuron 70 (4): 687–702. 10.1016/j.neuron.2011.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ottoboni Linda, Merlini Arianna, and Martino Gianvito. 2017. “Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System.” Frontiers in Cell and Developmental Biology 5 (May). 10.3389/fcell.2017.00052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ourednik Jitka, Ourednik Václav, William P Lynch Melitta Schachner, and Snyder Evan Y. 2002. “Neural Stem Cells Display an Inherent Mechanism for Rescuing Dysfunctional Neurons.” Nature Biotechnology 20 (11): 1103–10. 10.1038/nbt750. [DOI] [PubMed] [Google Scholar]
  37. Pirkmajer Sergej, and Chibalin Alexander V.. 2011. “Serum Starvation: Caveat Emptor.” American Journal of Physiology - Cell Physiology 301 (2): 272–79. 10.1152/ajpcell.00091.2011. [DOI] [PubMed] [Google Scholar]
  38. Rabenstein Monika, Hucklenbroich Joerg, Willuweit Antje, Ladwig Anne, Gereon Rudolf Fink Michael Schroeter, Langen Karl-Josef, and Rueger Maria Adele. 2015. “Osteopontin Mediates Survival, Proliferation and Migration of Neural Stem Cells through the Chemokine Receptor CXCR4.” Stem Cell Research & Therapy 6 (1): 99 10.1186/s13287-015-0098-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rothenberg Daniel A., Taliaferro J. Matthew, Huber Sabrina M., Begley Thomas J., Dedon Peter C., and White Forest M.. 2018. “A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth.” IScience 9: 367–81. 10.1016/j.isci.2018.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ryu Jae K, Jean Kim, Sung J Cho, Kozo Hatori, Astushi Nagai, Hyun B Choi, Min C Lee, James G McLarnon, and Seung U Kim. 2004. “Proactive Transplantation of Human Neural Stem Cells Prevents Degeneration of Striatal Neurons in a Rat Model of Huntington Disease.” Neurobiology of Disease 16 (1): 68–77. 10.1016/J.NBD.2004.01.016. [DOI] [PubMed] [Google Scholar]
  41. Shahdadfar Aboulghassem, Katrine Frønsdal Terje Haug, Reinholt Finn P., and Brinchmann Jan E.. 2005. “In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability.” Stem Cells 23 (9): 1357–66. 10.1634/stemcells.2005-0094. [DOI] [PubMed] [Google Scholar]
  42. Shen Faping, Song Chunyan, Liu Yunmian, Zhang Jing, and Song Sonya Wei. 2019. “IGFBP2 Promotes Neural Stem Cell Maintenance and Proliferation Differentially Associated with Glioblastoma Subtypes.” Brain Research 1704 (February): 174–86. 10.1016/J.BRAINRES.2018.10.018. [DOI] [PubMed] [Google Scholar]
  43. Shin Jaehoon, Berg Daniel A., Zhu Yunhua, Shin Joseph Y., Song Juan, Bonaguidi Michael A., Enikolopov Grigori, et al. 2015. “Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades Underlying Adult Neurogenesis.” Cell Stem Cell 17 (3): 360–72. 10.1016/j.stem.2015.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Shinoda Kosaku, Masaru Tomita, and Yasushi Ishihama. 2009. “EmPAI Calc-for the Estimation of Protein Abundance from Large-Scale Identification Data by Liquid Chromatography-Tandem Mass Spectrometry.” Bioinformatics 26 (4): 576–77. 10.1093/bioinformatics/btp700. [DOI] [PubMed] [Google Scholar]
  45. Skalnikova Helena, Motlik Jan, Gadher Suresh Jivan, and Kovarova Hana. 2011. “Mapping of the Secretome of Primary Isolates of Mammalian Cells, Stem Cells and Derived Cell Lines.” PROTEOMICS 11 (4): 691–708. 10.1002/pmic.201000402. [DOI] [PubMed] [Google Scholar]
  46. Tang Changyong, Wang Min, Wang Peijian, Wang Lei, Wu Qingfeng, and Guo Weixiang. 2019. “Neural Stem Cells Behave as a Functional Niche for the Maturation of Newborn Neurons through the Secretion of PTN.” Neuron 101 (1): 32–44.e6. 10.1016/j.neuron.2018.10.051. [DOI] [PubMed] [Google Scholar]
  47. Teixeira Fábio, and Salgado António. 2020. “Mesenchymal Stem Cells Secretome: Current Trends and Future Challenges.” Neural Regeneration Research 15 (1): 75–77. 10.4103/1673-5374.264455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wernly Bernhard, Inês Gonçalves Attila Kiss, Paar Vera, Tobias Mösenlechner Michael Leisch, Santer David, et al. 2017. “Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction.” Biotechnology Journal 12 (9): 1600732 10.1002/biot.201600732. [DOI] [PubMed] [Google Scholar]
  49. Yasuhara Takao, Matsukawa Noriyuki, Hara Koichi, Yu Guolong, Xu Lin, Maki Mina, Kim Seung U., and Borlongan Cesario V.. 2006. “Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson’s Disease.” Journal of Neuroscience 26 (48): 12497–511. 10.1523/JNEUROSCI.3719-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zhao Sheng, and Fernald Russell D.. 2005. “Comprehensive Algorithm for Quantitative Real-Time Polymerase Chain Reaction.” Journal of Computational Biology 12 (8): 1047–64. 10.1089/cmb.2005.12.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zheng Grace X.Y., Jessica M. Terry, Phillip Belgrader, Paul Ryvkin, Zachary W. Bent, Ryan Wilson, Solongo B. Ziraldo, et al. 2017. “Massively Parallel Digital Transcriptional Profiling of Single Cells.” Nature Communications. 10.1038/ncomms14049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zhou Yi, Bond Allison M, Shade Jamie E, Zhu Yunhua, Davis Chung-Ha O, Wang Xinyuan, Su Yijing, et al. 2018. “Autocrine Mfge8 Signaling Prevents Developmental Exhaustion of the Adult Neural Stem Cell Pool.” Cell Stem Cell 23 (3): 444–452.e4. 10.1016/j.stem.2018.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zywitza Vera, Misios Aristotelis, Bunatyan Lena, Willnow Thomas E, and Rajewsky Nikolaus. 2018. “Single-Cell Transcriptomics Characterizes Cell Types in the Subventricular Zone and Uncovers Molecular Defects Impairing Adult Neurogenesis.” Cell Reports 25 (9): 2457–2469.e8. 10.1016/j.celrep.2018.11.003. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2
NIHMS1576778-supplement-2.pptx (1,023.1KB, pptx)
3
4
5
6
7
8
9
10
11
12

RESOURCES